FINDINGS OF SCIENTIFIC MISCONDUCT NIH Guide, Volume 26, Number 33, October 3, 1997 Department of Health and Human Services Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Xiaomin Shang, Ph.D., University of Texas Southwestern Medical Center: Based upon a report from the University of Texas Southwestern Medical Center, information obtained by the Office of Research Integrity (ORI) during its oversight review, and Dr. Shang\'s own admission, ORI found that Dr. Shang, a former postdoctoral fellow student in the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, engaged in scientific misconduct arising out of certain biomedical research supported by a training grant from the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). Specifically, Dr. Shang fabricated a chemiluminescent film of a Western blot by using a physical mask to alter the prior results showing lack of antibody specificity to a human steroid metabolizing isozyme, rather than replicating an experiment as requested by his mentor. The fabricated data were not published. Dr. Shang has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which he has voluntarily agreed, for the three (3) year period beginning September 29, 1997: (1) to exclude himself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) that any institution that submits an application for PHS support for a research project on which Dr. Shang\'s participation is proposed or which uses him in any capacity on PHS supported research or that submits a report of PHS-funded research in which he is involved must concurrently submit a plan for supervision of his duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of Dr. Shang\'s research contribution. The institution also must submit a copy of the supervisory plan to ORI. No scientific publications were required to be corrected as part of this Agreement. INQUIRIES For further information contact: Acting Director, Division of Research Investigations Office of Research Integrity 5515 Security Lane, Suite 700 Rockville, MD 20852 Telephone: (301) 443-5330
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